Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Hypertension patient who satisfied below condition at Visit 1.~  * patient who takes antihypertensive drug~    * 140mmHg \<= sitSBP \<= 200mmHg~ * patient who doesn't take antihypertensive drug~    * 160mmHg \<= sitSBP \<= 200mmHg~   * 140mmHg \<= sitSBP \<= 200mmHg at Visit 2~Exclusion Criteria:~* Patient who have received 4 or more antihypertensive drug~* Patient with 20mmHg of difference in sitSBP or 10mmHg of difference in sitDBP between 3 times of BP measuring at Visit 1~* Patient with sitDBP \>= 120mmHg at Visit 2~* Patient with secondary hypertension

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: EXPERIMENTAL): HCP1401
- Reference (Type: ACTIVE_COMPARATOR): HCP0605

Based on this trial design, predict the completion outcome and termination type (if applicable).